Table 5.
Changes in laboratory data before and 2 months after treatment
| TACE alone | TACE with TAI | |||||
|---|---|---|---|---|---|---|
| Baseline | 2 months after | P value | Baseline | 2 months after | P value | |
| Creatinine (mg/dL) | 1.02 ± 0.41 | 1.00 ± 0.32 | 0.54 | 0.75 ± 0.22 | 0.76 ± 0.24 | 0.44 |
| Platelets (×104/mm3) | 10.3 ± 4.7 | 8.3 ± 4.6 | 0.21 | 9.8 ± 4.6 | 11.7 ± 4.9 | 0.21 |
| ALT (IU/mL) | 65 ± 63 | 47 ± 42 | 0.17 | 54 ± 32 | 45 ± 30 | 0.18 |
| AST (IU/mL) | 65 ± 39 | 50 ± 38 | 0.16 | 67 ± 37 | 53 ± 32 | 0.19 |
| Albumin (g/dL) | 3.6 ± 0.5 | 3.5 ± 0.4 | 0.48 | 3.5 ± 0.5 | 3.4 ± 0.4 | 0.68 |
| Total bilirubin (mg/dL) | 1.1 ± 0.7 | 1.1 ± 0.6 | 0.65 | 1.3 ± 0.6 | 1.2 ± 0.5 | 0.38 |
| Prothrombin time (%) | 73.3 ± 11.9 | 75.8 ± 12.2 | 0.43 | 76.1 ± 11.5 | 77.5 ± 12.1 | 0.36 |
| Child–Pugh Score | 6.1 ± 1.7 | 6.2 ± 1.8 | 0.39 | 6.0 ± 1.4 | 6.2 ± 1.7 | 0.31 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; TACE, transcatheter arterial chemoembolization; TAI, transcatheter arterial infusion.